{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:00:32Z","timestamp":1780275632963,"version":"3.54.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"F.R.S-FNRS","award":["J004620F"],"award-info":[{"award-number":["J004620F"]}]},{"DOI":"10.13039\/501100008966","name":"Soci\u00e9t\u00e9 Francophone du Diab\u00e8te","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46173-x","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:19:34Z","timestamp":1775729974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of NAD\u207a repletion with Nicotinamide riboside on obesity-induced chronic kidney disease and renal cell lipotoxicity"],"prefix":"10.1038","volume":"16","author":[{"given":"Morgane","family":"Decarnoncle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Thirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Marlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Mar\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Rouz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Jadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Emilie","family":"Decl\u00e8ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Juszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"46173_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.34","volume":"3","author":"P Gonz\u00e1lez-Muniesa","year":"2017","unstructured":"Gonz\u00e1lez-Muniesa, P. et al. Obesity. Nat. Rev. Dis. Primers. 3, 17034 (2017).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"46173_CR2","volume":"5","author":"TS Han","year":"2016","unstructured":"Han, T. S. & Lean, M. E. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc. Dis. 5, 2048004016633371 (2016).","journal-title":"JRSM Cardiovasc. Dis."},{"key":"46173_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","volume":"91","author":"C Garofalo","year":"2017","unstructured":"Garofalo, C. et al. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 91, 1224\u20131235 (2017).","journal-title":"Kidney Int."},{"key":"46173_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrneph.2016.75","volume":"12","author":"VD D\u2019Agati","year":"2016","unstructured":"D\u2019Agati, V. D. et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat. Rev. Nephrol. 12, 453\u2013471 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"46173_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","volume":"2","author":"APJ de Vries","year":"2014","unstructured":"de Vries, A. P. J. et al. Fatty kidney: Emerging role of ectopic lipid in obesity-related renal disease. Lancet. Diabetes. Endocrinol. 2, 417\u2013426 (2014).","journal-title":"Lancet. Diabetes. Endocrinol."},{"key":"46173_CR6","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1681\/ASN.2016070731","volume":"28","author":"T Yamamoto","year":"2017","unstructured":"Yamamoto, T. et al. High-fat diet-induced lysosomal dysfunction and impaired autophagic flux contribute to lipotoxicity in the kidney. J. Am. Soc. Nephrol. JASN 28, 1534\u20131551 (2017).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"46173_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/ki.2013.462","volume":"85","author":"A-E Decl\u00e8ves","year":"2014","unstructured":"Decl\u00e8ves, A.-E. et al. Regulation of lipid accumulation by AMK-activated kinase in high fat diet\u2013induced kidney injury. Kidney Int. 85, 611\u2013623 (2014).","journal-title":"Kidney Int."},{"key":"46173_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010350","volume":"22","author":"F Juszczak","year":"2020","unstructured":"Juszczak, F. et al. Delayed exercise training improves obesity-induced chronic kidney disease by activating AMPK pathway in high-fat diet-fed mice. Int. J. Mol. Sci. 22, 350 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"46173_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13293-023-00543-6","volume":"14","author":"F Juszczak","year":"2023","unstructured":"Juszczak, F. et al. Sex differences in obesity-induced renal lipid accumulation revealed by lipidomics: a role of adiponectin\/AMPK axis. Biol. Sex Differ. 14, 63 (2023).","journal-title":"Biol. Sex Differ."},{"key":"46173_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-03122-4","volume":"11","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction. Cell. Death. Dis. 11, 1\u201314 (2020).","journal-title":"Cell. Death. Dis."},{"key":"46173_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrneph.2018.9","volume":"14","author":"JM Forbes","year":"2018","unstructured":"Forbes, J. M. & Thorburn, D. R. Mitochondrial dysfunction in diabetic kidney disease. Nat. Rev. Nephrol. 14, 291\u2013312 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"46173_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.kint.2016.06.013","volume":"90","author":"HH Szeto","year":"2016","unstructured":"Szeto, H. H. et al. Protection of mitochondria prevents high-fat diet\u2013induced glomerulopathy and proximal tubular injury. Kidney Int. 90, 997\u20131011 (2016).","journal-title":"Kidney Int."},{"key":"46173_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s42255-023-00761-7","volume":"5","author":"T Doke","year":"2023","unstructured":"Doke, T. et al. NAD+ precursor supplementation prevents mtRNA\/RIG-I-dependent inflammation during kidney injury. Nat. Metab. 5, 414\u2013430 (2023).","journal-title":"Nat. Metab."},{"key":"46173_CR14","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41591-018-0138-z","volume":"24","author":"A Poyan Mehr","year":"2018","unstructured":"Poyan Mehr, A. et al. De novo NAD+ biosynthetic impairment in acute kidney injury in humans. Nat. Med. 24, 1351\u20131359 (2018).","journal-title":"Nat. Med."},{"key":"46173_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010021","volume":"12","author":"L Chanvillard","year":"2022","unstructured":"Chanvillard, L., Tammaro, A. & Sorrentino, V. NAD+ metabolism and interventions in premature renal aging and chronic kidney disease. Cells 12, 21 (2022).","journal-title":"Cells"},{"key":"46173_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136936","volume":"25","author":"F Juszczak","year":"2024","unstructured":"Juszczak, F., Arnould, T. & Decl\u00e8ves, A.-E. The role of mitochondrial sirtuins (SIRT3, SIRT4 and SIRT5) in renal cell metabolism: Implication for kidney diseases. Int. J. Mol. Sci. 25, 6936 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"46173_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.exger.2012.08.007","volume":"48","author":"AS Bause","year":"2013","unstructured":"Bause, A. S. & Haigis, M. C. SIRT3 regulation of mitochondrial oxidative stress. Exp. Gerontol. 48, 634\u2013639 (2013).","journal-title":"Exp. Gerontol."},{"key":"46173_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/CIRCRESAHA.117.310933","volume":"121","author":"AE Dikalova","year":"2017","unstructured":"Dikalova, A. E. et al. Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension. Circ. Res. 121, 564\u2013574 (2017).","journal-title":"Circ. Res."},{"key":"46173_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/embor.2011.65","volume":"12","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 12, 534\u2013541 (2011).","journal-title":"EMBO Rep."},{"key":"46173_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/ijms24010137","volume":"24","author":"M Morevati","year":"2023","unstructured":"Morevati, M. et al. Roles of NAD+ in acute and chronic kidney diseases. Int. J. Mol. Sci. 24, 137 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"46173_CR21","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.18632\/aging.103410","volume":"12","author":"Y Ogura","year":"2020","unstructured":"Ogura, Y., Kitada, M., Xu, J., Monno, I. & Koya, D. CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+\/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats. Aging 12, 11325\u201311336 (2020).","journal-title":"Aging"},{"key":"46173_CR22","first-page":"1","volume":"5","author":"N Xie","year":"2020","unstructured":"Xie, N. et al. NAD+ metabolism: Pathophysiologic mechanisms and therapeutic potential. Signal Transduct. Target. Ther. 5, 1\u201337 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"46173_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3945\/jn.116.230078","volume":"146","author":"SA Trammell","year":"2016","unstructured":"Trammell, S. A., Yu, L., Redpath, P., Migaud, M. E. & Brenner, C. Nicotinamide riboside is a major NAD+ precursor vitamin in cow milk. J. Nutr. 146, 957\u2013963 (2016).","journal-title":"J. Nutr."},{"key":"46173_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cell.2007.03.024","volume":"129","author":"P Belenky","year":"2007","unstructured":"Belenky, P. et al. Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1\/Pnp1\/Meu1 pathways to NAD+. Cell 129, 473\u2013484 (2007).","journal-title":"Cell"},{"key":"46173_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","volume":"117","author":"P Bieganowski","year":"2004","unstructured":"Bieganowski, P. & Brenner, C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 117, 495\u2013502 (2004).","journal-title":"Cell"},{"key":"46173_CR26","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.1038\/ncomms12948","volume":"7","author":"SAJ Trammell","year":"2016","unstructured":"Trammell, S. A. J. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).","journal-title":"Nat. Commun."},{"key":"46173_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino, J., Baur, J. A. & Imai, S. NAD+ intermediates: The biology and therapeutic potential of NMN and NR. Cell Metab. 27, 513\u2013528 (2018).","journal-title":"Cell Metab."},{"key":"46173_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3, C. et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838\u2013847 (2012).","journal-title":"Cell Metab."},{"key":"46173_CR29","doi-asserted-by":"publisher","first-page":"F118","DOI":"10.1152\/ajprenal.00110.2008","volume":"296","author":"N Deji","year":"2009","unstructured":"Deji, N. et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol.-Ren. Physiol. 296, F118\u2013F126 (2009).","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"46173_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1042\/BJ20100791","volume":"433","author":"AA Kendrick","year":"2011","unstructured":"Kendrick, A. A. et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 433, 505\u2013514 (2011).","journal-title":"Biochem. J."},{"key":"46173_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","volume":"44","author":"MD Hirschey","year":"2011","unstructured":"Hirschey, M. D. et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177\u2013190 (2011).","journal-title":"Mol. Cell"},{"key":"46173_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 13, 629\u2013646 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"46173_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41419-021-04469-y","volume":"13","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. BNIP3L\/NIX-mediated mitophagy: molecular mechanisms and implications for human disease. Cell Death Dis. 13, 14 (2021).","journal-title":"Cell Death Dis."},{"key":"46173_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.109058","volume":"107","author":"M-B Kim","year":"2022","unstructured":"Kim, M.-B. et al. Nicotinamide riboside supplementation exerts an anti\u2013obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice. J. Nutr. Biochem. 107, 109058 (2022).","journal-title":"J. Nutr. Biochem."},{"issue":"24","key":"46173_CR35","doi-asserted-by":"publisher","first-page":"01094","DOI":"10.1016\/j.tjnut.2024.10.017","volume":"S0022\u20133166","author":"A-J Zhou","year":"2024","unstructured":"Zhou, A.-J. et al. Long-Term administration of nicotinamide mononucleotide mitigates high-fat-diet-induced physiological decline in aging mice. J. Nutr. S0022\u20133166(24), 01094. https:\/\/doi.org\/10.1016\/j.tjnut.2024.10.017 (2024).","journal-title":"J. Nutr."},{"issue":"3","key":"46173_CR36","doi-asserted-by":"publisher","first-page":"e164626","DOI":"10.1172\/jci.insight.164626","volume":"8","author":"J-D Morel","year":"2023","unstructured":"Morel, J.-D. et al. Mitochondrial and NAD+ metabolism predict recovery from acute kidney injury in a diverse mouse population. JCI Insight 8(3), e164626 (2023).","journal-title":"JCI Insight"},{"key":"46173_CR37","doi-asserted-by":"publisher","first-page":"1384953","DOI":"10.3389\/fendo.2024.1384953","volume":"15","author":"S Yang","year":"2024","unstructured":"Yang, S., Gong, W., Wang, Y., Hao, C. & Guan, Y. Unraveling the nexus of NAD+ metabolism and diabetic kidney disease: insights from murine models and human data. Front. Endocrinol. 15, 1384953 (2024).","journal-title":"Front. Endocrinol."},{"key":"46173_CR38","doi-asserted-by":"publisher","first-page":"e153019","DOI":"10.1172\/jci.insight.153019","volume":"7","author":"Y Bignon","year":"2022","unstructured":"Bignon, Y. et al. Cell stress response impairs de novo NAD+ biosynthesis in the kidney. JCI Insight 7, e153019 (2022).","journal-title":"JCI Insight"},{"key":"46173_CR39","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1681\/ASN.2016040385","volume":"28","author":"Y Guan","year":"2017","unstructured":"Guan, Y. et al. Nicotinamide mononucleotide, an NAD+ precursor, rescues age-associated susceptibility to AKI in a sirtuin 1\u2013dependent manner. J. Am. Soc. Nephrol. JASN 28, 2337 (2017).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"46173_CR40","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature17184","volume":"531","author":"MT Tran","year":"2016","unstructured":"Tran, M. T. et al. PGC1\u03b1-dependent NAD biosynthesis links oxidative metabolism to renal protection. Nature 531, 528 (2016).","journal-title":"Nature"},{"key":"46173_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.649547","volume":"12","author":"Y Jia","year":"2021","unstructured":"Jia, Y. et al. Nicotinamide mononucleotide attenuates renal interstitial fibrosis after AKI by suppressing tubular DNA damage and senescence. Front. Physiol. 12, 649547 (2021).","journal-title":"Front. Physiol."},{"key":"46173_CR42","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001826R","volume":"35","author":"R Zapata-P\u00e9rez","year":"2021","unstructured":"Zapata-P\u00e9rez, R. et al. Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice. FASEB J. 35, e21456 (2021).","journal-title":"FASEB J."},{"key":"46173_CR43","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1194\/jlr.M088690","volume":"60","author":"A-E Decl\u00e8ves","year":"2019","unstructured":"Decl\u00e8ves, A.-E. et al. AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice. J. Lipid Res. 60, 937\u2013952 (2019).","journal-title":"J. Lipid Res."},{"key":"46173_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1530\/JOE-21-0123","volume":"251","author":"DM Cartwright","year":"2021","unstructured":"Cartwright, D. M. et al. Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity. J. Endocrinol. 251, 111\u2013123 (2021).","journal-title":"J. Endocrinol."},{"key":"46173_CR45","doi-asserted-by":"publisher","first-page":"103635","DOI":"10.1016\/j.isci.2021.103635","volume":"25","author":"AS Williams","year":"2022","unstructured":"Williams, A. S. et al. Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome. iScience 25, 103635 (2022).","journal-title":"iScience"},{"key":"46173_CR46","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.bbadis.2019.06.009","volume":"1865","author":"TX Pham","year":"2019","unstructured":"Pham, T. X. et al. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. Biochimica et Biophysica Acta (BBA) 1865, 2451\u20132463 (2019).","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"46173_CR47","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","volume":"12","author":"X Qiu","year":"2010","unstructured":"Qiu, X., Brown, K., Hirschey, M. D., Verdin, E. & Chen, D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 12, 662\u2013667 (2010).","journal-title":"Cell Metab."},{"key":"46173_CR48","doi-asserted-by":"publisher","first-page":"10665","DOI":"10.1038\/s41598-020-67812-x","volume":"10","author":"D Thapa","year":"2020","unstructured":"Thapa, D. et al. Cardiomyocyte-specific deletion of GCN5L1 in mice restricts mitochondrial protein hyperacetylation in response to a high fat diet. Sci. Rep. 10, 10665 (2020).","journal-title":"Sci. Rep."},{"key":"46173_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jacl.2023.07.005","volume":"17","author":"CE Annevelink","year":"2023","unstructured":"Annevelink, C. E., Sapp, P. A., Petersen, K. S., Shearer, G. C. & Kris-Etherton, P. M. Diet-derived and diet-related endogenously produced Palmitic Acid: Effects on metabolic regulation and cardiovascular disease risk. J. Clin. Lipidol. 17, 577\u2013586 (2023).","journal-title":"J. Clin. Lipidol."},{"key":"46173_CR50","first-page":"7702","volume":"25","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Berberine (BBR) attenuated palmitic acid (PA)-induced Lipotoxicity in human HK-2 cells by promoting peroxisome proliferator-activated receptor a (PPAR-a). Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 25, 7702 (2019).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"46173_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000487673","volume":"43","author":"T Liu","year":"2018","unstructured":"Liu, T. et al. Palmitic acid-induced podocyte apoptosis via the reactive oxygen species-dependent mitochondrial pathway. Kidney Blood Press. Res. 43, 206\u2013219 (2018).","journal-title":"Kidney Blood Press. Res."},{"key":"46173_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/155486272435238","author":"L Pierre","year":"2024","unstructured":"Pierre, L. et al. (2024) AMPK protects proximal tubular epithelial cells from lysosomal dysfunction and dedifferentiation induced by lipotoxicity. Autophagy https:\/\/doi.org\/10.1080\/155486272435238 (2024).","journal-title":"Autophagy"},{"key":"46173_CR53","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cmet.2016.09.004","volume":"24","author":"EF Fang","year":"2016","unstructured":"Fang, E. F. et al. NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 24, 566\u2013581 (2016).","journal-title":"Cell Metab."},{"key":"46173_CR54","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.celrep.2018.05.009","volume":"23","author":"DC Sch\u00f6ndorf","year":"2018","unstructured":"Sch\u00f6ndorf, D. C. et al. The NAD+ precursor Nicotinamide Riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson\u2019s Disease. Cell Rep. 23, 2976\u20132988 (2018).","journal-title":"Cell Rep."},{"key":"46173_CR55","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1038\/s41467-019-13172-8","volume":"10","author":"EF Fang","year":"2019","unstructured":"Fang, E. F. et al. NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome. Nat. Commun. 10, 5284 (2019).","journal-title":"Nat. Commun."},{"key":"46173_CR56","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.28245","volume":"63","author":"K Gariani","year":"2016","unstructured":"Gariani, K. et al. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology 63, 1190 (2016).","journal-title":"Hepatology"},{"key":"46173_CR57","doi-asserted-by":"publisher","first-page":"eadd5163","DOI":"10.1126\/sciadv.add5163","volume":"9","author":"HAK Lapatto","year":"2023","unstructured":"Lapatto, H. A. K. et al. Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study. Sci. Adv. 9, eadd5163 (2023).","journal-title":"Sci. Adv."},{"key":"46173_CR58","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-020-2741-7","volume":"588","author":"TS Luongo","year":"2020","unstructured":"Luongo, T. S. et al. SLC25A51 is a mammalian mitochondrial NAD+ transporter. Nature 588, 174\u2013179 (2020).","journal-title":"Nature"},{"key":"46173_CR59","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3390\/nu11102439","volume":"11","author":"W Shi","year":"2019","unstructured":"Shi, W. et al. High dose of dietary nicotinamide riboside induces glucose intolerance and white adipose tissue dysfunction in mice fed a mildly obesogenic diet. Nutrients 11, 2439 (2019).","journal-title":"Nutrients"},{"key":"46173_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600878","volume":"61","author":"W Shi","year":"2017","unstructured":"Shi, W. et al. Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet. Mol. Nutr. Food Res. 61, 1600878 (2017).","journal-title":"Mol. Nutr. Food Res."},{"key":"46173_CR61","first-page":"409","volume":"65","author":"J-E Ryu","year":"2015","unstructured":"Ryu, J.-E. et al. Evaluation of nonalcoholic fatty liver disease in C57BL\/6J mice by using MRI and histopathologic analyses. Comp. Med. 65, 409\u2013415 (2015).","journal-title":"Comp. Med."},{"key":"46173_CR62","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/sj.bjc.6602181","volume":"91","author":"F Journe","year":"2004","unstructured":"Journe, F. et al. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells. Br. J. Cancer 91, 1703\u20131710 (2004).","journal-title":"Br. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46173-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46173-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46173-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:01:53Z","timestamp":1780272113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46173-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46173"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46173-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16750"}}